U.S. Drug Testing Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Sample (Urine Samples), By Drug (Alcohol, Opioids), By End Use (Drug Testing Laboratories, Workplaces, Hospitals), And Segment Forecasts, 2026 - 2033

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Sample type
  • 1.2.3. Drug type
  • 1.2.4. End use
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Objectives
  • 1.3.1. Objective-1
  • 1.3.2. Objective-2
  • 1.3.3. Objective-3
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased database
  • 1.5.2. GVR's internal database
  • 1.5.3. Secondary sources
  • 1.5.4. Primary research
• 1.6. Information or Data Analysis
  • 1.6.1. Data analysis models
• 1.7. Market Formulation & Validation
• 1.8. Model Details
  • 1.8.1. Commodity flow analysis
    • 1.8.1.1. Approach 1: Commodity flow approach
    • 1.8.1.2. Approach 2: Country-wise market estimation using bottom-up approach
• 1.9. List of Secondary Sources
• 1.10. List of Primary Sources
• 1.11. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Product Snapshot
• 2.3. Sample Snapshot
• 2.4. Drug and End-use Snapshot
• 2.5. Competitive Insights

Chapter 3. U.S. Drug Testing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook (Drug Testing Market)
  • 3.1.2. Related/ancillary market outlook (Drug Screening Market)
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising prevalence of substance abuse
    • 3.2.1.2. Stringent regulations requiring drug and alcohol testing
    • 3.2.1.3. Growing government efforts to curb substance abuse
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Stringent regulatory framework for drug testing products
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Expansion of testing in new industries
    • 3.2.3.2. Policies like the Affordable Care Act (ACA)
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Economic Downturns
    • 3.2.4.2. Reduction in corporate spending
• 3.3. U.S. Drug Testing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape
• 3.4. Regulatory Framework
• 3.5. Reimbursement Scenario

Chapter 4. U.S. Drug Testing Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Drug Testing Market: Product Movement Analysis
• 4.3. U.S. Drug Testing Market by Product Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. Consumables
  • 4.5.1. Consumables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Instruments
  • 4.6.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6.2. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Rapid Testing Devices
  • 4.7.1. Rapid Testing Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7.2. Rapid Testing Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Services
  • 4.8.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8.2. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Drug Testing Market: Sample Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Drug Testing Market: Sample Type Movement Analysis
• 5.3. U.S. Drug Testing Market by Sample Type Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. Urine Samples
  • 5.5.1. Urine Samples Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.2. Urine Samples Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
• 5.6. Oral Fluid Samples
  • 5.6.1. Oral Fluid Samples Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6.2. Oral Fluid Samples Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Hair Samples
  • 5.7.1. Hair Samples Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7.2. Hair Samples Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Other Sample
  • 5.8.1. Other Sample Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8.2. Other Sample Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Drug Testing Market: Drug Type Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Drug Testing Market: Drug Type Movement Analysis
• 6.3. U.S. Drug Testing Market by Drug Type Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.5. Alcohol
  • 6.5.1. Alcohol Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.2. Alcohol Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Cannabis/Marijuana
  • 6.6.1. Cannabis/Marijuana Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.2. Cannabis/Marijuana Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Cocaine
  • 6.7.1. Cocaine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.2. Cocaine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Opioids
  • 6.8.1. Opioids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8.2. Opioids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.9. Amphetamine & Methamphetamine
  • 6.9.1. Amphetamine & Methamphetamine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9.2. Amphetamine & Methamphetamine Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
• 6.10. LSD
  • 6.10.1. LSD Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.10.2. LSD Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
• 6.11. Others
  • 6.11.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.11.2. Others Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 7. U.S. Drug Testing Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. U.S. Drug Testing Market: End Use Movement Analysis
• 7.3. U.S. Drug Testing Market by End Use Outlook (USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 7.5. Drug Testing Laboratories
  • 7.5.1. Drug Testing Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. Drug Testing Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
• 7.6. Workplaces
  • 7.6.1. Workplaces Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Workplaces Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
• 7.7. Hospitals
  • 7.7.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)
• 7.8. Others
  • 7.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.2. Others Market Revenue Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Recent Developments & Impact Analysis by Key Market Participants
• 8.3. Company Market Share Analysis, 2025
• 8.4. Key Company Profiles
  • 8.4.1. Quest Diagnostics Incorporated
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Abbott
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Laboratory Corporation of America Holdings (Labcorp)
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Thermo Fisher Scientific, Inc.
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. OraSure Technologies, Inc.
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Psychemedics Corporation
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Omega Laboratories, Inc
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Premier Biotech, Inc
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Alfa Scientific Designs, Inc
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S. drug testing market, by product, 2021 - 2033 (USD Million)
• Table 4 U.S. drug testing market, by sample, 2021 - 2033 (USD Million)
• Table 5 The detection span for drugs using urine samples
• Table 6 The detection span for drugs using oral fluid samples
• Table 7 The detection span for drugs using hair samples
• Table 8 U.S. drug testing market, by drug, 2021 - 2033 (USD Million)
• Table 9 U.S. drug testing market, by end use, 2021 - 2033 (USD Million)
• Table 10 Key players involved in mergers and acquisitions
• Table 11 Key players involved in partnerships and collaboration
• Table 12 Key players involved in new product launch
• Table 13 Key players involved in other strategies

List of Figures

• Fig. 1 U.S. drug testing market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modelling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 U.S. drug testing market snapshot
• Fig. 10 Test snapshot
• Fig. 11 Application and end-use snapshot
• Fig. 12 Competitive landscape snapshot
• Fig. 13 Parent market outlook
• Fig. 14 Related/ancillary market outlook
• Fig. 15 Market dynamics
• Fig. 16 Market driver analysis (current & future impact)
• Fig. 17 Market restraint analysis (current & future impact)
• Fig. 18 Porter's five forces analysis
• Fig. 19 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 20 Industry analysis - Porter's
• Fig. 21 U.S. drug testing market Product outlook key takeaways
• Fig. 22 U.S. drug testing market, Product movement analysis
• Fig. 23 Consumables market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 24 Instruments market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 25 Rapid testing devices market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 26 Services market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 27 U.S. drug testing market: Sample type outlook and key takeaways
• Fig. 28 U.S. drug testing market: Sample type movement analysis
• Fig. 29 Urine samples market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 30 Oral fluid samples market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 31 Hair samples market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 32 Other sample market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 33 U.S. drug testing market: Drug type outlook and key takeaways
• Fig. 34 U.S. drug testing market: Drug type movement analysis
• Fig. 35 Alcohol market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 36 Cannabis/Marijuana market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 37 Cocaine market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 38 Opioids market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 39 Amphetamine & methamphetamine market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 40 LSD market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 41 LSD drug use in the past year among people aged 12 or older; by age group, 2021, in U.S.
• Fig. 42 Others market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 43 U.S. drug testing market: End use outlook and key takeaways
• Fig. 44 U.S. drug testing market: End use movement analysis
• Fig. 45 Drug testing laboratories market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 46 Workplaces market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 47 Hospitals market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 48 Others market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 49 Alcohol use disorder diagnose among age groups
• Fig. 50 Key company categorization
• Fig. 51 U.S. drug testing market share analysis, 2025
• Fig. 52 Strategy mapping